AI Medical Service
AI Medical Service Inc. (AIM) is a Tokyo-based med-tech company founded in September 2017 with the mission to save lives worldwide by eliminating gastrointestinal cancers through earlier detection. AIM develops endoscopic AI (artificial intelligence) that assists physicians in real-time diagnostic imaging of the digestive tract, drawing on joint research with more than 100 medical institutions. Its flagship gastroAI family of endoscopic image diagnosis support software has secured regulatory approval in Japan, Singapore, and Thailand, and an earlier FDA approval in the United States. The company distributes its AI on-premise today and is building an in-house cloud platform to broaden access; it currently publishes no public developer API, OpenAPI specification, or developer portal. This API Evangelist profile tracks the company as a health-tech lead backed by SoftBank Vision Fund.
AI Medical Service is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Artificial Intelligence, Medical Imaging, and Endoscopy.
AI Medical Service’s developer surface includes product news and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 2
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 1
Properties that don't map to a standard resource type